Search
for
Sort by
Research 211–240 of 1000+
- Polycystic ovary syndrome — the skin as a mirror of endocrine disorders
- Plant-based approaches in the management of polycystic ovary syndrome: A review
- Botanical Treatment for Polycystic Ovary Syndrome
- Endocrine evaluation of hirsutism
- Inhibition of 5α Reductase Impairs Cognitive Performance, Alters Dendritic Morphology and Increases Tau Phosphorylation in the Hippocampus of Male 3xTg-AD Mice
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- THE MULTIFACETED APPROACH TO POLYCYSTIC OVARIAN SYNDROME: A REVIEW OF TRADITIONAL AND ALLOPATHIC MEDICINE
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Female Adolescent Hair Disorders
- Organizational Effects of Estrogens and Androgens on Estrogen and Androgen Receptor Expression in Pituitary and Adrenal Glands in Adult Male and Female Rats
- Severe Hyperandrogenism in A Premenopausal Woman With An Imaging-Negative Leydig Cell Tumor
- A systematic review of antiandrogens and feminization in transgender women
- Maternal androgen excess significantly impairs sexual behavior in male and female mouse offspring: Perspective for a biological origin of sexual dysfunction in PCOS
- Pelvic ultrasound and color Doppler findings in different isosexual precocities
- Comparative advantage and efficacy of natural products for polycystic ovary syndrome
- Changes in Prolactin and Insulin Resistance in PCOS Patients Undergoing Metformin Treatment: A Retrospective Study
- Leydig cell hyperplasia as a cause of virilization in a postmenopausal woman: A case report
- On the effects of testosterone on brain behavioral functions
- Use of Myoinositol in PCOS
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Treatment options for polycystic ovary syndrome
- Androgen biosynthetic pathways in the human prostate
- Tamoxifen for flutamide/finasteride-induced gynecomastia
- Ketoconazole use in the treatment of ovarian hyperandrogenism
- Polycystic Ovary Syndrome and the Metabolic Syndrome Long-Term Risks
- Hair loss in women
- Anti-androgen therapy in polyendocrine metabolic ovary syndrome (PMOS, formerly PCOS): efficacy, safety, and phenotype-oriented clinical decision-making
- Anabolic androgenic steroids and carcinogenicity focusing on Leydig cell: a literature review
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- A narrative review on cutaneous manifestations in polycystic ovary syndrome: pathophysiology, diagnosis, management, and psychosocial impact